Prelude Capital Management’s Achillion Pharmaceuticals, Inc. ACHN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-33,635
| Closed | -$203K | – | 1830 |
|
|
2019
Q4 | $203K | Buy |
+33,635
| New | +$203K | 0.01% | 535 |
|
|
2017
Q3 | – | Sell |
-2,200
| Closed | -$10K | – | 1896 |
|
|
2017
Q2 | $10K | Sell |
2,200
-6,900
| -76% | -$31.4K | ﹤0.01% | 1279 |
|
|
2017
Q1 | $38K | Buy |
+9,100
| New | +$38K | ﹤0.01% | 1064 |
|
|
2016
Q4 | – | Sell |
-3,000
| Closed | -$24K | – | 1832 |
|
|
2016
Q3 | $24K | Buy |
+3,000
| New | +$24K | ﹤0.01% | 1239 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 2064 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 1995 |
|
|
2013
Q4 | – | Sell |
-22,900
| Closed | -$69K | – | 1904 |
|
|
2013
Q3 | $69K | Sell |
22,900
-101,432
| -82% | -$306K | 0.01% | 780 |
|
|
2013
Q2 | $1.02M | Buy |
+124,332
| New | +$1.02M | 0.22% | 88 |
|